[HTML][HTML] mRNA vaccines for infectious diseases: principles, delivery and clinical translation
N Chaudhary, D Weissman… - Nature reviews Drug …, 2021 - nature.com
Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a
scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the …
scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the …
The epidemiology, diagnosis and treatment of COVID-19
P Zhai, Y Ding, X Wu, J Long, Y Zhong, Y Li - International journal of …, 2020 - Elsevier
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
[HTML][HTML] New vaccine technologies to combat outbreak situations
Ever since the development of the first vaccine more than 200 years ago, vaccinations have
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
mRNA vaccines for COVID-19 and diverse diseases
Since its outbreak in late 2019, the novel coronavirus disease 2019 (COVID-19) has spread
to every continent on the planet. The global pandemic has affected human health and …
to every continent on the planet. The global pandemic has affected human health and …
[HTML][HTML] Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster …
AM Henao-Restrepo, A Camacho, IM Longini… - The Lancet, 2017 - thelancet.com
Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-
based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …
[PDF][PDF] Collaborative study report on blood coagulation factor IX: Expert Committee on Biological Standardization: Geneva, 12 to 16 October 2015
World Health Organization… - 2015 - apps.who.int
There are three main aims for this collaborative study: 1. to add a FIX antigen value to the 4
th International Standard for Blood Coagulation Factors II, VII, IX and X, Plasma, Human …
th International Standard for Blood Coagulation Factors II, VII, IX and X, Plasma, Human …
[HTML][HTML] Ebola virus disease
D Malvy, AK McElroy, H de Clerck, S Günther… - The Lancet, 2019 - thelancet.com
Ebolaviruses are pathogenic agents associated with a severe, potentially fatal, systemic
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
[HTML][HTML] A recombinant vesicular stomatitis virus Ebola vaccine
JA Regules, JH Beigel, KM Paolino… - … England Journal of …, 2017 - Mass Medical Soc
Background The worst Ebola virus disease (EVD) outbreak in history has resulted in more
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
[HTML][HTML] Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
S Wang, B Liang, W Wang, L Li, N Feng… - … and Targeted Therapy, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …
challenges to public health security and the global economy. The development and …